Garofalo, M., Wieczorek, M., Anders, I., Staniszewska, M., Lazniewski, M., Prygiel, M., . . . Kuryk, L. (2023). Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model. Frontiers in Oncology, 1-13. https://doi.org/10.3389/fonc.2023.1259314

Garofalo, Mariangela, et al. "Novel Combinatorial Therapy of Oncolytic Adenovirus AdV5/3-D24-ICOSL-CD40L with Anti PD-1 Exhibits Enhanced Anti-cancer Efficacy Through Promotion of Intratumoral T-cell Infiltration and Modulation of Tumour Microenvironment in Mesothelioma Mouse Model." Frontiers in Oncology 2023: 1-13. https://doi.org/10.3389/fonc.2023.1259314.

Garofalo, Mariangela, et al. "Novel Combinatorial Therapy of Oncolytic Adenovirus AdV5/3-D24-ICOSL-CD40L with Anti PD-1 Exhibits Enhanced Anti-cancer Efficacy Through Promotion of Intratumoral T-cell Infiltration and Modulation of Tumour Microenvironment in Mesothelioma Mouse Model." Frontiers in Oncology, 2023, pp. 1-13, https://doi.org/10.3389/fonc.2023.1259314.